Lumefantrine , >98.0%(HPLC) , 82186-77-4
Synonym(s):
(9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-9H-fluorene-4-methanol;Benflumetol;CPG-56695;Lumefantrine
CAS NO.:82186-77-4
Empirical Formula: C30H32Cl3NO
Molecular Weight: 528.94
MDL number: MFCD05662268
EINECS: 617-303-4
Pack Size | Price | Stock | Quantity |
1g | RMB39.20 | In Stock |
|
5G | RMB70.40 | In Stock |
|
25G | RMB204.00 | In Stock |
|
100G | RMB646.40 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 129-131°C |
Boiling point: | 642.5±55.0 °C(Predicted) |
Density | 1.252 |
storage temp. | 15-25°C |
solubility | DMSO: ≥20mg/mL |
form | powder |
pka | 13.44±0.20(Predicted) |
color | yellow |
Merck | 14,5597 |
Description and Uses
Lumefantrine is a derivative of halofantrine that has been reported to exhibit antimalarial activity when combined with artemether in the treatment of multidrug-resistant Plasmodium falciparium . No evidence of cardiotoxicity has been reported with this combination, which may offer promise for successful treatment of resistant organisms.
Lumefantrine has been used:
to study its effect on ex-vivo?Plasmodium falciparum?sensitivity using the tritiated hypoxanthine-based assay
as a standard in the quantification of combined tablet formulation using HPTLC
as a drug molecule in in vitro growth inhibition assay for in vitro B. caballi?growth inhibition studies
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P305+P351+P338 |
WGK Germany | 3 |
HS Code | 29221950 |